WWM
TEVA icon

Western Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Western Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-49,984
Closed -$400K – 846
2021
Q4 		$400K Buy
+49,984
New +$451K 0.04% 378
2021
Q1 		– Sell
-17,319
Closed -$167K – 539
2020
Q4 		$167K Sell
17,319
-699
-4% -$6.7K 0.02% 457
2020
Q3 		$162K Buy
+18,018
New +$191K 0.03% 422

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Western Wealth Management's TEVA Position: Q1 2022 in Review

Western Wealth Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2022, closing a stake of 49,984 shares — an estimated $400K sold.

Western Wealth Management first reported a position in TEVA in Q3 2020 and held it in 3 quarters. The position peaked at $400K in Q4 2021. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2022.

  • Western Wealth Management reported no remaining Teva Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Western Wealth Management sold 49,984 Teva Pharmaceuticals shares in Q1 2022, an estimated $400K.
  • Western Wealth Management first reported a position in Teva Pharmaceuticals in Q3 2020 and held it in 3 quarters.
  • Western Wealth Management's Teva Pharmaceuticals position peaked at $400K in Q4 2021.
  • 438 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2022.

Based on Western Wealth Management's 13F filing for Q1 2022, filed 10 May 2022.